About 2010 Perfect Vision
20/10 PERFECT VISION OPERATIONS GmbH of Heidelberg, Germany, develops, manufactures and markets technologies for raising refractive surgery well beyond current expectations. The company's expertise lies in diagnostic as well as therapeutic technologies. 20/10 PERFECT VISION's FEMTEC femtosecond laser workstation is set to revolutionize the ophthalmic surgery market, while keeping ease-of-use and patient safety as primary objectives.
2010 Perfect Vision Frequently Asked Questions (FAQ)
When was 2010 Perfect Vision founded?
2010 Perfect Vision was founded in 1999.
What is 2010 Perfect Vision's latest funding round?
2010 Perfect Vision's latest funding round is Other Investors.
Who are the investors of 2010 Perfect Vision?
Investors of 2010 Perfect Vision include TechFund Europe, 123 Investment Managers, NBGI Ventures, Entrepreneurs Fund, LBBW Venture Capital and 9 more.
Who are 2010 Perfect Vision's competitors?
Competitors of 2010 Perfect Vision include Digital Surgery Systems, Cardiva Medical, Mercator MedSystems, Light Sciences Oncology, CardiAQ Valve Technologies and 13 more.
Compare 2010 Perfect Vision to Competitors
Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.
Mercator MedSystems has developed a broad-based therapeutic platform that allows clinicians to accurately and efficiently deliver drugs and biologics such as stem cells to tissues deep in the body, treating the root cause of significant medical conditions. The company utilizes its family of Micro-Infusion Catheters for targeted treatments via the vascular system, including peripheral artery disease (PAD) and resistant hypertension (HTN); and via the bronchial tree, including malignant airway obstruction secondary to lung cancer. The company's 510(k)-cleared and CE-Marked Cricket and Bullfrog Micro-Infusion Catheters are vascular-access systems that are able to inject drugs, genes, and cells safely through vessel walls into deep tissues without major surgery.
ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;n Developed a ever vascular stapling technology for stapling synthetic grafts to the aortan Developed endovascular devices for EVAR and SFA procedures
eNeura Therapeutics develops the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraines.
NAS Medical develops, manufactures, and sells radiation therapy products for use in cancer treatment.
Rafael Medical has developed a novel anchoring system for safely implanting and retrieving a wide range of intra-vascular devices in a minimally invasive manner. Based on the technology, diagnostic and therapeutic devices can be delivered into small and large blood vessels alike by way of a small-sized delivery system. Following the completion of the SafeFlo Filter the company is now developing additional devices geared to the interventional cardiology market.